Dr. Reddy's Laboratories Limited
RDY
#1885
Rank
$10.179 B
Marketcap
India
Country
$12.22
Share price
-1.85%
Change (1 day)
-19.14%
Change (1 year)
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that…
Key Metrics
Trailing P/E
27.48
Forward P/E
0.19
EPS (TTM)
$0.42
Forward EPS
$0.65
Price / Book
14.19
EV / EBITDA
1.0x
Beta
0.24
Dividend Yield
0.70%
Return on Equity
8.84%
Return on Assets
4.01%
Debt / Equity
18.61
Current Ratio
1.90
Gross Margin
50.18%
Operating Margin
4.25%
Net Profit Margin
10.00%
Free Cash Flow
$-3,909,625,088
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 17 – Sep 15
-4.71%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$3.562B
Latest Net Income$454.401M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Dr. Reddy's Laboratories Limited with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
RDY
No recent news available. Set FINNHUB_API_KEY to enable news.
